Became listed on the Main Board of the Hong Kong Stock Exchange, primarily engaged in property development

Business transformation process of the Group:

Sino Harbour Bio Technology Holdings Group Limited was established to engage in healthcare business

Jiangxi Hanyun Incubator Limited was established to assist the Group in seeking suitable development opportunities

Sino Harbour Bio Technology Limited was established to engage in the business of healthcare

Sino Harbour Bio Technology Limited signed a strategic cooperation framework agreement to enter the pharmaceutical inspection industry

The Group changed its name to Sino Harbour Holdings Group Limited, which marked the Group’s determination to engage in both real estate and healthcare industries.

Jiangxi Asia City Real Estate Development Company Limited signed a subscription agreement to subscribe for the 30% equity interest in Zhejiang Davi Pharmaceutical Co., Ltd.

Sino Harbour Bio Technology Limited signed an agreement to formally enter the pharmaceutical inspection industry

Sino Harbour Bio Technology Limited signed a strategic cooperation framework agreement to enter the stem cell industry

Jiangxi Sino Harbour Technology Limited signed a framework agreement to enter the stem cell business of the Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region

Guangxi Gangrun Bio Technology Limited was established

Zhejiang IPS Pharmaceutical Technology Co., Ltd. was established

Zhejiang Sino Harbour Bio Technology Limited invested in Jiangxi LongYu Medicine Co., Ltd.

Guangxi Gangrun Bio Technology Limited signed a stem cell technical cooperation agreement with the Second Affiliated Hospital of Guilin Medical University to further expand its stem cell business in Guangxi Zhuang Autonomous Region